Trials / Unknown
UnknownNCT00270517
Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia
A Randomized, Double-Blinded, Parallel Group, Multicenter Study of EDP-420 Versus Telithromycin for the Treatment of Community Acquired Pneumonia
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 250 (planned)
- Sponsor
- Enanta Pharmaceuticals, Inc · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will compare the efficacy, safety and tolerability of EDP-420 versus another oral antibiotic in the treatment of community acquired pneumonia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EDP-420 / Duration of Treatment - 3 days | |
| DRUG | Telithromycin / Duration of Treatment - 7 days |
Timeline
- Start date
- 2005-12-01
- Completion
- 2007-07-01
- First posted
- 2005-12-28
- Last updated
- 2006-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00270517. Inclusion in this directory is not an endorsement.